Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-10 Sale | 2024-12-11 5:17 pm | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $9.4622 | $283,866 | 747,663 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 7:39 pm | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $9.27 | $278,100 | 777,663 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-10 Exercise | 2024-12-11 5:17 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $0 | 747,663 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-11 5:17 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $2.781 | 747,663 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-27 7:39 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $0 | 777,663 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-27 7:39 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $2.781 | 777,663 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 34,157 | $4.13 | 651,291 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-02 8:51 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 47,162 | $3.41 | 685,448 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 297,600 | $0 | 905,210 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:17 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 633,646 | $0 | 965,670 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 4:16 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 31,819 | $7 | 330,314 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-01 9:49 pm | N/A 2032-01-31 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 875,700 | $0 | 875,700 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:52 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO | 342,000 | $0 | 342,000 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-13 7:00 pm | N/A 2030-07-08 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO | 75,000 | $0 | 75,000 (Direct) | View |
Ownership | 2020-07-09 6:00 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO | 0 | $0 | 348,836 (Direct) | View |